Avantor Results Presentation Deck

Q4 highlights Executing well in a challenging environment Strongest revenue growth quarter of 2020 Solid margin expansion and cash flow generation - - Continued focus on growth strategy Enhanced bioproduction offering through technology launches including: TopMixer modular media and buffer prep mixing system SterilEnzTM high-pressure fluid handling solution Commercialized controlled-release drug delivery technology for HIV prevention application Completed transformation of Avantor capital structure enabling financial flexibility - Actively supporting COVID-19 vaccine production Ongoing supply and capacity investments to support all vaccine modalities Commercialized silicone elastomer to support ultra low temperature single-use solution avantor M

View entire presentation